知镜 Cognispect · 医学文献与研究工作台

Early experience with sotatercept in adult patients with repaired and unrepaired congenital heart disease and pulmonary hypertension.

Gao H, Channick R, Saggar R, Troy M, Lin J, Lluri G, Reardon L, Aboulhosn J.
International journal of cardiology. Congenital heart disease · 2026-10-14 · PMID 43022630

文献摘要

Background Pulmonary arterial hypertension associated with congenital heart disease (ACHD-PAH) is a condition underrepresented in initial clinical trials investigating sotatercept, a first-in-class activin signaling inhibitor. Patients with unrepaired defects or complex congenital heart disease were excluded from these trials. Here, we describe real-world outcomes in a cohort of ACHD-PAH patients treated with sotatercept. Methods A single-center retrospective review was performed of 14 adults with ACHD-PAH initiated on sotatercept between May 2024 and January 2026. Patients had heterogeneous congenital anatomy; with half having unrepaired defects. Paired pre- and post-treatment measures were compared, and each patient served as their own control, over a median follow-up of 542 days. Results Eleven of 14 patients (79%) continued therapy. Three patients discontinued: one for epistaxis and two for clinical deterioration leading to heart-lung transplant listing. Adverse effects occurred in 50% of patients, most commonly epistaxis (43%). Hemoglobin increased by a median of 1.5 g/dL (p = 0.002). Symptomatic improvement was reported by 79%, and 29% improved by at least one WHO functional class. Exertional oxygen-saturation nadir improved in 71%. Echocardiography showed favorable subpulmonary ventricular remodeling, with increased fractional area change (+5.0%, p = 0.020) and reductions in right ventricular basal, mid-chamber, and longitudinal dimensions (all p ≤ 0.03). Lack of response was associated with advanced disease, pulmonary veno-occlusive physiology, and systemic ventricular dysfunction. Conclusions In this cohort of ACHD-PAH patients, sotatercept was generally well-tolerated and was associated with symptomatic improvement and echocardiographic signs of favorable ventricular remodeling.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。